Do Analysts Think Jaguar Health Inc (JAGX) Is Still Worth Buying In 2024?

Jaguar Health Inc (NASDAQ:JAGX) does about 45.08M shares in volume on a normal day but saw 114068019 shares change hands in Monday trading. The company now has a market cap of 24.80M USD. Its current market price is $0.12, marking an increase of 31.56% compared to the previous close of $0.09. The 52 week high reached by this stock is $1.22 whilst the lowest price level in 52 weeks is $0.05.

Jaguar Health Inc (JAGX) has a 20-day trading average at $0.0832 and the current price is -90.26% off the 52-week high compared with 132.03% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.0815 and its 200-day simple moving average is $0.2733. If we look at the stock’s price movements over the week, volatility stands at 25.43%, which decreases to 17.94% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 62.13 to suggest the stock is neutral.

The consensus objective for the share price is $6.00, suggesting that the stock has a potential upside of 98.0% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 07, 2021 when Cantor Fitzgerald initiated the stock to “Overweight” and issued a price target of $5.

Jaguar Health Inc (JAGX) stock is up 44.88% over the week and 58.19% over the past month. Its price is -21.53% year-to-date and -79.80% over the past year.

To reach the target analysts have set, the stock logically needs to grow 98.0 percent from here.

The company has a return on investment of -112.11% and return on equity of -1919.14%. The beta has a value of 1.35. Price to book ratio is 1.75 and price to sales ratio is 2.54.